VYROLOGIX
Dead / Abandoned — Abandoned — no statement of use filed (as of 17 Oct 2022)
What this means for you
This application is over — abandoned 17 Oct 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90610911
- Mark type
- Stylized text
- Filed
- 29 Mar 2021
- Published for opposition
- 18 Jan 2022
- Abandoned
- 17 Oct 2022
- Attorney of record
- Jared M. Barrett
Goods and services
- Class 005 — Pharmaceuticals: therapeutic preparations for the treatment of respiratory diseases and disorders; therapeutic preparations for the treatment of COVID-19; therapeutic preparations, namely, antibodies for the purpose of targeting the CCR5 cell receptor of cells and inhibiting or blocking the channel signaling of the CCR5 cell receptor for medical treatment
Owner
- CytoDyn Inc., Vancouver, WA, US
- CytoDyn Inc., Vancouver, WA, US
Prosecution history
- 17 Oct 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 17 Oct 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Mar 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Jan 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jan 2022 — PUBLISHED FOR OPPOSITION
- 29 Dec 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Dec 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Dec 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Dec 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Dec 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Dec 2021 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 04 Dec 2021 — PRIORITY ACTION E-MAILED
- 04 Dec 2021 — PRIORITY ACTION WRITTEN
- 18 Nov 2021 — ASSIGNED TO EXAMINER
- 06 Jul 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED